Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Scheme 1
GLP-1 receptor agonists are injectable medications for type 2 diabetes and weight management that mimic the incretin hormone GLP-1
Regarding dosage , the Phase 2 trial investigated several dose levels administered as a once-weekly subcutaneous injection, ranging from 1 mg up to 12 mg per week , with a gradual escalation schedule
Formulation-wise, the products are functionally identical
Significant reductions were observed for K-18 with the 8 mg and 12 mg doses of retatrutide (up to 49.6%) and for pro-C3 with all doses of retatrutide (up to 26.4%)
Through those, you could pay between $349 and $499 per month for Zepbounds vial and syringe and $499 a month for Wegovy in the auto-injector pen
US$ 22.54
US$ 26.79
US$ 27.49
US$ 21.51
US$ 26.32
US$ 27.18
US$ 20.42
US$ 21.82
US$ 26.94
US$ 29.68
US$ 24.82
US$ 28.77
US$ 26.67
